Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Hughes

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
The Lancet. Oncology|April 17, 2016
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trialJeffrey H Lipton, Charles Chuah, Agnès Guerci-Bresler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 4, 2025
Assessing the Global Impact of Brain Small Vessel Disease on Cognition: The Multi-Ethnic Study of AtherosclerosisSokratis Charisis, Tanweer Rashid, Christina Dintica, et al.
Cold Spring Harbor Perspectives in Biology|July 19, 2017
Role of the β Common (βc) Family of Cytokines in Health and DiseaseTimothy R Hercus, Winnie L T Kan, Sophie E Broughton, et al.
Blood|August 20, 2010
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNAHelen E White, Paul Matejtschuk, Peter Rigsby, et al.
Scientific Reports|December 29, 2018
Meta-analysis of Alzheimer's disease on 9,751 samples from Norway and IGAP study identifies four risk lociAree Witoelar, Arvid Rongve, Ina S Almdahl, et al.
The New England Journal of Medicine|December 8, 2006
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemiaBrian J Druker, François Guilhot, Stephen G O'Brien, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
The Lancet. Oncology|April 17, 2016
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trialJeffrey H Lipton, Charles Chuah, Agnès Guerci-Bresler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 4, 2025
Assessing the Global Impact of Brain Small Vessel Disease on Cognition: The Multi-Ethnic Study of AtherosclerosisSokratis Charisis, Tanweer Rashid, Christina Dintica, et al.
Cold Spring Harbor Perspectives in Biology|July 19, 2017
Role of the β Common (βc) Family of Cytokines in Health and DiseaseTimothy R Hercus, Winnie L T Kan, Sophie E Broughton, et al.
Blood|August 20, 2010
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNAHelen E White, Paul Matejtschuk, Peter Rigsby, et al.
Scientific Reports|December 29, 2018
Meta-analysis of Alzheimer's disease on 9,751 samples from Norway and IGAP study identifies four risk lociAree Witoelar, Arvid Rongve, Ina S Almdahl, et al.
The New England Journal of Medicine|December 8, 2006
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemiaBrian J Druker, François Guilhot, Stephen G O'Brien, et al.
Pageof 15